Cash Flow - CRISPR Therapeutics AG (CRSP)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -345.01 | -142.77 | -260.38 | -495.74 | 538.97 | -238.37 | 56.68 | -96.24 | -70.10 | -55.31 | 59.43 | -4.79 |
| Cash flow from investing | -31.81 | -280.48 | 374.65 | -258.66 | -1,035.43 | -541.17 | 1.33 | -2.77 | -8.31 | 31.88 | -1.15 | -1.15 |
| Cash flow from financing | 426.03 | 331.98 | 62.66 | 38.59 | 250.95 | 1,016.15 | 430.98 | 315.93 | 2.61 | 183.22 | 96.73 | 5.12 |
| Change in cash | 49.21 | -91.27 | 176.94 | -715.80 | -245.51 | 236.62 | 488.99 | 216.92 | -75.76 | 159.56 | 155.01 | -0.82 |
| Change in exchange rate | 0.04 | -0.24 | ||||||||||
Show Quarterly Cash Flow
Cash Flow - CRISPR Therapeutics AG (CRSP)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | Dec-19 | Sep-19 | Jun-19 | Mar-19 | Dec-18 | Sep-18 | Jun-18 | Mar-18 | Dec-17 | Sep-17 | Jun-17 | Mar-17 | Dec-16 | Sep-16 | Jun-16 | Mar-16 | Dec-15 | Sep-15 | Jun-15 | Mar-15 | Dec-14 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -108.90 | -92.55 | -84.63 | -113.88 | -53.95 | -50.03 | -106.91 | -95.58 | 109.75 | -96.07 | -39.86 | -133.25 | 8.80 | -113.33 | -105.22 | -141.96 | -135.24 | -86.04 | -81.33 | 807.00 | -100.66 | -81.21 | -75.70 | -29.28 | -52.18 | 3.38 | 133.42 | -36.38 | -43.74 | -28.37 | -19.96 | -25.22 | -22.69 | -14.84 | -15.87 | -15.98 | -23.41 | -19.42 | -12.28 | -13.60 | -10.01 | 69.00 | -5.31 | -2.68 | -1.58 | -4.79 |
| Cash flow from investing | -410.74 | 37.20 | -119.23 | 69.98 | -19.76 | 105.83 | -161.60 | -126.91 | -97.80 | -81.45 | 121.35 | 216.92 | 117.83 | -175.53 | 87.46 | -56.07 | -114.52 | -8.72 | -565.18 | -293.64 | -167.90 | -204.24 | -330.33 | -3.61 | -2.99 | 7.06 | -2.46 | -2.17 | -1.10 | -1.00 | -0.70 | -0.52 | -0.56 | -0.21 | -3.49 | -1.33 | -3.29 | 14.77 | -1.51 | -1.05 | 19.67 | -0.50 | -0.55 | -0.10 | -1.15 | |
| Cash flow from financing | 591.91 | 116.41 | 296.77 | 2.26 | 10.59 | 16.88 | 9.64 | -0.47 | 305.93 | 38.94 | 1.56 | 16.77 | 5.40 | 2.48 | 15.11 | 10.35 | 10.65 | 6.30 | 10.21 | 8.44 | 225.99 | 412.63 | 512.89 | 89.51 | 1.13 | 304.72 | 70.89 | 29.65 | 25.73 | -1.27 | 188.22 | 3.73 | 125.25 | 1.28 | 0.61 | 0.70 | 0.02 | 91.77 | -4.47 | 60.93 | 35.00 | 38.48 | 52.96 | 5.29 | 5.12 | |
| Change in cash | 72.27 | 61.06 | 92.91 | -41.65 | -63.11 | 72.67 | -258.88 | -222.95 | 317.89 | -138.59 | 83.05 | 100.44 | 132.03 | -286.38 | -2.64 | -187.68 | -239.11 | -88.46 | -636.30 | 521.81 | -42.57 | 127.17 | 106.86 | 56.62 | -54.03 | 315.15 | 201.84 | -8.90 | -19.11 | -30.64 | 167.56 | -22.01 | 102.02 | -13.76 | -18.75 | -16.61 | -26.65 | 87.12 | -18.26 | 46.27 | 44.65 | 106.98 | -5.86 | 50.18 | 3.71 | -0.82 |
| Change in exchange rate | 0.01 | 0.01 | 0.00 | 0.03 | ||||||||||||||||||||||||||||||||||||||||||